Skip to main content
. 2023 Jul 2;62(7):2891–2904. doi: 10.1007/s00394-023-03201-0

Table 3.

Associations of post-diagnostic energy-adjusted intake of total dairy, low-fat dairy, high-fat dairy, and dairy products with recurrence (n = 1215) and all-cause mortality (n = 1605) in sex-specific quartiles of people with stage I-III colorectal cancer

Dietary variable Recurrencea All-cause mortality
Median energy-adjusted intake [IQR]b n No. of recurrences/person-years Adjusted model, HR (95% CI)c Median energy-adjusted intake [IQR]b n No. of deaths/
person-years
Adjusted model, HR (95% CI)c
Total dairy
 Q1 125.3 [92.7, 157.9] 305 31/889 1.00 125.7 [90.8, 157.9] 396 51/2211 1.00
 Q2 227.7 [206.4, 257.8] 304 41/899 1.38 (0.86–2.21) 228.1 [206.6, 254.1] 403 59/2186 1.06 (0.73–1.55)
 Q3 341.6 [318.2, 365.7] 303 39/842 1.31 (0.81–2.10) 335.1 [303.5, 362.6] 400 60/2161 1.07 (0.73–1.55)
 Q4 485.9 [440.2, 606.7] 303 39/853 1.27 (0.79–2.04) 481.4 [434.8, 593.7] 406 65/2272 1.00 (0.69–1.45)
 Ptrend NA NA NA 0.47 NA NA NA 0.94
 Continuous (per 100 g/day) 285.1 [184.7, 396.6] 1215 150/3484 1.06 (0.97–1.16) 282.7 [185.9, 393.7] 1605 235/8829 1.03 (0.95–1.10)
Low-fat dairyd
 Q1 23.0 [0.3, 46.7] 302 37/871 1.00 20.1 [− 1.7, 46.2] 396 66/2151 1.00
 Q2 120.1 [94.4, 140.1] 305 36/897 0.95 (0.60–1.50) 119.3 [94.9, 139.8] 402 58/2220 0.83 (0.58–1.18)
 Q3 221.7 [187.0, 259.4] 304 36/852 1.03 (0.65–1.63) 216.9 [180.6, 255.5] 402 52/2211 0.70 (0.49–1.01)
 Q4 382.6 [322.3, 470.0] 304 41/864 1.14 (0.73–1.78) 380.3 [322.6, 469.4] 405 59/2247 0.76 (0.53–1.08)
 Ptrend NA NA NA 0.48 NA NA NA 0.12
 Continuous (per 100 g/day) 161.0 [71.3, 288.0] 1215 150/3484 1.03 (0.94–1.13) 161.2 [72.0, 286.6] 1605 235/8829 *
High-fat dairye
 Q1 29.2 [13.2, 40.9] 307 40/853 1.00 29.2 [13.5, 40.0] 400 43/2213 1.00
 Q2 64.7 [54.8, 73.0] 304 33/902 0.80 (0.50–1.30) 64.9 [54.0, 73.0] 403 61/2232 1.27 (0.85–1.89)
 Q3 102.9 [90.7, 115.9] 305 32/895 0.77 (0.48–1.24) 102.2 [90.4, 116.2] 405 49/2249 0.94 (0.62–1.44)
 Q4 209.7 [168.5, 291.9] 299 45/834 1.02 (0.66–1.57) 202.7 [166.1, 273.6] 397 82/2135 1.60 (1.10–2.33)
 Ptrend NA NA NA 0.62 NA NA NA 0.010
 Continuous (per 100 g/day) 81.2 [48.4, 136.6] 1215 150/3484 1.08 (0.93–1.24) 81.2 [48.5, 135.9] 1605 235/8829 1.18 (1.06–1.32)
Total milk
 Q1 − 0.4 [− 14.4, 8.4] 307 32/863 1.00 − 1.1 [− 15.3, 7.0] 394 57/2106 1.00
 Q2 32.9 [25.6, 42.8] 301 42/873 1.31 (0.82–2.10) 31.9 [24.1, 40.5] 401 54/2252 0.79 (0.53–1.17)
 Q3 104.6 [78.9, 133.8] 305 30/897 1.01 (0.61–1.67) 101.2 [75.7, 128.6] 403 50/2209 0.78 (0.53–1.15)
 Q4 256.2 [191.9, 306.5] 302 46/851 1.39 (0.88–2.19) 237.1 [183.6, 299.5] 407 74/2261 0.99 (0.70–1.42)
 Ptrend NA NA NA 0.28 NA NA NA 0.54
 Continuous (per 100 g/day) 58.8 [16.9, 159.8] 1215 150/3484 1.05 (0.93–1.18) 56.9 [16.4, 155.6] 1605 235/8829 1.02 (0.92–1.12)
Total yoghurt
 Q1 4.5 [− 4.3, 11.7] 301 30/888 1.00 4.2 [-4.4, 12.1] 397 62/2229 1.00
 Q2 45.7 [29.4, 58.9] 303 44/862 1.38 (0.86–2.20) 47.4 [29.1, 61.2] 402 62/2171 0.99 (0.70–1.41)
 Q3 104.1 [84.9, 121.7] 305 33/897 1.03 (0.63–1.69) 103.8 [82.9, 121.1] 402 56/2215 0.84 (0.58–1.20)
 Q4 187.3 [144.2, 266.7] 306 43/836 1.51 (0.96–2.39) 187.8 [143.8, 269.6] 404 55/2214 0.89 (0.62–1.28)
 Ptrend NA NA NA 0.39 NA NA NA 0.17
 Continuous (per 100 g/day) 76.3 [20.5, 136.8] 1215 150/3484 1.07 (0.91–1.27) 75.5 [21.7, 137.2] 1605 235/8829 0.96 (0.83–1.11)
Total cheese
 Q1 8.9 [3.3, 12.9] 303 37/848 1.00 8.1 [2.1, 12.6] 397 55/2133 1.00
 Q2 21.2 [18.9, 23.8] 301 47/825 1.37 (0.88–2.12) 21.1 [18.6, 23.4] 403 66/2193 1.02 (0.71–1.48)
 Q3 32.9 [29.6, 36.9] 305 34/889 0.92 (0.57–1.46) 32.7 [29.3, 36.5] 403 55/2247 0.86 (0.59–1.25)
 Q4 53.1 [46.8, 67.5] 306 32/921 0.83 (0.51–1.33) 52.4 [46.5, 66.4] 402 59/2257 0.89 (0.61–1.29)
 Ptrend NA NA NA 0.18 NA NA NA 0.40
 Continuous (per 30 g/day) 26.3 [16.3, 40.9] 1215 150/3484 0.85 (0.68–1.07) 26.1 [15.9, 40.4] 1605 235/8829 0.93 (0.78–1.11)

CI confidence interval, HR hazard ratio; IQR inter-quartile range. Cut-off points for female quartiles were as follows: 208.8, 317.5 and 418.1 g/day for total dairy; 91.2, 181.8 and 303.1 g/day for low-fat dairy; 61.0, 89.8 and 145.5 g/day for high-fat dairy; 21.7, 52.0 and 153.5 g/day for milk; 45.1, 102.9 and 152.5 g/day for yoghurt; 18.5, 28.2 and 42.4 g/day for cheese. Cut-off points for male quartiles were as follows: 166.9, 263.2 and 375.3 g/day for total dairy; 61.6, 147.3 and 270.6 g/day for low-fat dairy; 42.5, 74.0 and 129.1 g/day for high-fat dairy; 12.7, 59.4 and 155.5 g/day for milk; 14.0, 58.7 and 121.9 g/day for yoghurt; 14.1, 24.4 and 39.4 g/day for cheese

*This association was observed to be non-linear in restricted cubic splines. See Fig. 2 for the continuous analysis

aRecurrence is defined as a locoregional recurrence or distant metastasis. Participants were excluded from data analysis when they had missing data on recurrence status (n = 419), when they had no surgery (n = 8) or when they had a recurrence before filling out the post-diagnostic FFQ (n = 9)

bDietary intake was adjusted for energy using the energy residual method. To improve interpretability, the predicted nutrient intake at the median total energy intake was added to individual residuals [15]

cThe adjusted model was adjusted for age, sex, stage of disease and post-diagnostic energy intake

dLow-fat dairy included buttermilk and low-fat, reduced-fat or skimmed versions of milk, yoghurt, custard, and soft curd cheese

eHigh-fat dairy included whole and condensed milk, full-fat versions of yoghurt, custard and soft curd cheese, all other cheeses, ice cream, whipped cream, and butter